Faruqi & Faruqi, LLP Announces Investigation of Continucare Corp.

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Continucare Corp. (“Continucare” or the “Company”) (NYSE: CNU) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Metropolitan Health Networks Inc. (“Metropolitan”) (AMEX: MDF) in a deal valued at approximately $416 million. Under the terms of the proposed transaction, Continucare shareholders will receive $6.25 in cash and 0.0414 of Metropolitan common stock for each share. Shareholders who collectively own approximately 43% of Continucare outstanding stock have already approved the merger.